SABS icon

SAB Biotherapeutics

34 hedge funds and large institutions have $25.4M invested in SAB Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
-7
Holders Change %
-17.07%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
28
Increased
3
Reduced
3
Closed
35
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
BCM
51
Beryl Capital Management
California
-$1.86M -18,489 Closed
SCM
52
Saba Capital Management
New York
-$1.52M -15,065 Closed
PMAM
53
Picton Mahoney Asset Management
Ontario, Canada
-$1.51M -15,000 Closed
AA
54
AQR Arbitrage
Connecticut
-$1.14M -11,286 Closed
RCM
55
Rivernorth Capital Management
Florida
-$1.01M -10,000 Closed
D.E. Shaw & Co
56
D.E. Shaw & Co
New York
-$838K -8,318 Closed
WAM
57
Weiss Asset Management
Massachusetts
-$660K -6,548 Closed
Tudor Investment Corp
58
Tudor Investment Corp
Connecticut
-$605K -6,000 Closed
AWG
59
Alpha Wave Global
New York
-$517K -5,133 Closed
CM
60
Crestline Management
Texas
-$510K -5,061 Closed
DWM
61
Dakota Wealth Management
Florida
-$510K -5,058 Closed
Jane Street
62
Jane Street
New York
-$360K -3,572 Closed
EAM
63
Exos Asset Management
New York
-$355K -3,526 Closed
LCM
64
Landscape Capital Management
New Jersey
-$229K -2,272 Closed
Walleye Capital
65
Walleye Capital
New York
-$201 -1,995 Closed
TCM
66
Tenor Capital Management
New York
-$154K -1,527 Closed
Walleye Trading
67
Walleye Trading
New York
-$134K -1,330 Closed
LP
68
LMR Partners
United Kingdom
-$109K -1,085 Closed
GCL
69
Glazer Capital LLC
New York
-$13K -133 Closed